Skip to content
2000
Volume 14, Issue 36
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Circulating endothelial cell (CEC) and progenitor (CEP) number and viability are modulated in various pathological conditions including cancer. There is increasing evidence showing that CEC and CEP play a role in cancer progression and metastasis in different animal models. At the clinical level, emerging data support that CEC and CEP kinetics and viability might predict the efficacy on anticancer drug combinations that include antiangiogenic agents. On the basis of these observations, CEC and CEP measurements have attractive potential diagnostic and therapeutic applications for malignant diseases.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161208786898635
2008-12-01
2025-05-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161208786898635
Loading

  • Article Type:
    Research Article
Keyword(s): Angiogenesis; cancer; endothelial cells; endothelial progenitors; tumor; vasculogenesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test